Penn Integrates Knowledge professor Michael Platt holds appointments in the Department of Psychology in the School of Arts & Sciences, the Department of Neuroscience in the Perelman School of Medicine, and the Marketing Department in the Wharton School.
What the brain reveals in nature’s subtle game of give and take
Research led by Michael Platt uncovers the neural pathways for primate reciprocity, social support, and empathy.
Recipients of the 2023 President’s Innovation Prize, team Sonura, five bioengineering graduates from the School of Engineering and Applied Science, have created a device that filters out disruptive environmental noises for infants in neonatal intensive care units. Their beanie offers protection and fosters parental connection to newborns while also supporting their development.
nocred
2023 PIP/PEP winners: Where are they now?
Nearly a year after the winners of the President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) began their projects, the winners—now alumni—discuss their progress.
Archaea, a unique domain of life, were discovered in the 1970s in extreme environments such as hot springs and salty lakes, with notable early studies conducted in locations like Yellowstone National Park in the United States. Initially considered unusual bacteria, their distinct genetics and biochemistry led to their recognition as a separate domain, emphasizing microbial diversity and evolutionary complexity.
(Image: iStock / rmbarricarte)
Structural elements of archaea
Researchers shed light on archea, a single cell microorganism, to discover how proteins determine what shape a cell will take and how that form may function.
Alonso Carrasco-Labra of Penn Dental Medicine is director of the Cochrane Oral Health Collaborating Center.
(Image: Penn Dental Medicine)
New guideline on acute dental pain management
In collaboration with the American Dental Association and University of Pittsburgh, Penn’s School of Dental Medicine has issued a new guideline for managing acute dental pain in adolescents, adults, and older adults.
Weitzman students at the Penn Biden Center in Washington, D.C. with Oksana Markarova (Ukrainian Ambassador to the United States), Dorothy McAuliffe (U.S. Special Representative for Global Partnerships, Department of State), John Thompson (Deputy Assistant Secretary for Environment, Department of State) and Eugenie Birch (co-director, Penn IUR).
(Image: Courtesy of the U.S. Department of State)
Penn students present work to help rebuild Ukrainian city
With the two-year anniversary of the Russian full-scale invasion of Ukraine looming, city planners begin to strategize solutions to rebuild, sustainably.
Bispecific T cell engagers are emerging as a powerful class of immunotherapy to treat cancer but are sometimes hindered by unwanted outcomes, such as on-target, off-tumor toxicity; cytokine release syndrome; and neurotoxicity. Now, researchers Penn researchers have developed a novel “switchable” bispecific T cell engager that mitigates these negative effects by co-opting a drug already approved by the FDA.
(Image: iStock / CIPhotos)
‘Switchable’ bispecific antibodies pave way for safer cancer treatment
Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy.
Martin Claassen of the School of Arts & Sciences and Jiaoyang Huang of the Wharton School each has been selected to receive a 2024 Sloan Research Fellowship, which recognizes early career scientists in North America. They are among 126 chosen this year to receive the two-year, $75,000 fellowship, in recognition of their accomplishments, creativity, and potential to become leaders in their fields.
nocred
Martin Claassen and Jiaoyang Huang named 2024 Sloan Research Fellows
Two from Penn honored as early career researchers and scholars for their accomplishments, creativity, and potential to become leaders in their fields.
Many deaths during the pandemic which were not listed as /COVID-related may have, in fact, been as a result of COVID. In a collaborative study, researchers in the School of Arts & Sciences found that increases in non-COVID excess deaths occurred at the same time or in the month prior to increases in reported COVID-19 deaths in most U.S. counties, indicating that many COVID deaths went uncounted as such.
(Image: iStock/BriVisu)
‘Natural’ deaths likely COVID-19 related
New study led by Penn and Boston University provides the most compelling data yet to suggest excess mortality rates from chronic illnesses and other natural causes were driven by COVID-19 infections.
